As of 2025-06-03, the EV/EBITDA ratio of Adamas Pharmaceuticals Inc (ADMS) is -10.98. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ADMS's latest enterprise value is 424.04 mil USD. ADMS's TTM EBITDA according to its financial statements is -38.62 mil USD. Dividing these 2 quantities gives us the above ADMS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.0x - 10.7x | 9.0x |
| Forward P/E multiples | 10.9x - 20.7x | 15.6x |
| Fair Price | (10.37) - (10.17) | (11.58) |
| Upside | -226.2% - -223.7% | -240.9% |
| Date | EV/EBITDA |